VOLUNTARY ANNOUNCEMENT MARKETING AUTHORIZATION APPLICATION FOR LECANKITUG INJECTION ACCEPTED FOR REVIEW BY CHINA’S NATIONAL MEDICAL PRODUCTS ADMINISTRATION
(I) RE-ELECTION OF THE BOARD OF DIRECTORS; (II) ELECTION OF EMPLOYEE REPRESENTATIVE DIIRECTOR; (III) CHANGES IN THE COMPOSITION OF BOARD COMMITTEES; AND (IV) APPOINTMENT OF SENIOR MANAGEMENT ANISECURITIES AFFAIRS REPRESENTATIVE